Biotech News

The new treatment option is being introduced through OncoBeta's partnership with Greek medical technology company, Mediray

Genprex, Inc. (N A S D A Q: GNPX) Provides New Clinical Patient Analysis Uncovers Promising TUSC2-Associated Biological Activity Involving Mitochondrial Function, Cellular Repair, Autophagy and Protein Quality Control. Combined With the Roche Diagnostics

Canadian biotechnology company InnuScience and Thai partner Peerapat Technology plan to start local bottling in January 2027.

Strategic Roche Diagnostics Partnership, New Biomarker Findings and Expanding Clinical Research Could Help Transform Patient Selection for Non-Small Cell Lung Cancer Treatment, While Genprex, Inc. (N A S D A Q: GNPX) Advances Additional Opportunities in S

NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP Also Received an $11 Million Dollar Award for Robotic Magnetic Stimulation with Pharma Treatment for Resistant Depression

Preclinical study of the first-in-class, brain-penetrant OLIG2 inhibitor will be presented at the 31st Annual Meeting of the Society for Neuro-Oncology

CELLKEY AI Officially Launches Omics Marketplace 'OmicsPharm'

At Booth 6511B, Natural Field connected with international buyers and manufacturers, with discussions spanning liposomal ingredients, sports nutrition, botanical extracts, and customized formulation solutions.

A Landmark October 30th FDA Approval, Commercial Manufacturing Readiness, Two-Year Stability Results, and an $11.25 Million DARPA Research Contract Put NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) at an Important Turning Point in Its Growth

Roche Diagnostics $RHHBY Collaboration, Promising REQORSA® Biomarker Research, and Expanding Gene Therapy Programs Put Genprex $GNPX in the Spotlight

$SNNC acquires Majority Stake in New Joint Venture With Doc-Rx Opens the Door to Telehealth, U.S.-Made Peptides and an Ambitious Wellness Clinic Expansion Strategy

Foundational preclinical study of the first-in-class, brain-penetrant OLIG2 inhibitor supports evaluating CT-179 with standard-of-care therapy, including in MGMT-unmethylated glioblastoma, where temozolomide adds little

Comprehensive HPLC and ESI-MS purity verification parameters established to support scientific integrity in laboratory research.

MINNEAPOLIS - -- Nor-Tech, a leading integrator of high-performance computing (HPC) and AI solutions, just announced its AI ProServer, available with NVIDIA H200 or L40S GPUs. Engineered for demanding artificial intelligence workloads, the AI ProServer...

XI'AN, China - -- Booth 6511B will feature sports nutrition ingredients, botanical extracts, and liposomal ingredients for supplement brands and manufacturers. Natural Field, a B2B supplier of nutraceutical raw material powders, will exhibit at...

Seven months after launch, the B2B peptide directory explains why it was built, how its confidence scores work, and what it plans next.

NRXP Reports Three Successfully Manufactured Commercial Lots, Two-Year Stability Data, and Commercially Releasable Supply Pending FDA Approval — While an $11.18 Million DARPA Contract Expands the Company's Research Opportunities

United Medical Centers, a federally qualified health center serving Kinney, Maverick, and Val Verde counties, has joined a network that brings border communities into the clinical research shaping patient care.

Manufacturers in one of the world's leading pharmaceutical spray-drying centers point to power, permitting, logistics, and workforce as the limits on Oregon expansion.

October 15 FDA Update Confirms Minor Labeling Changes Ahead of November 10 Goal Date, While an $11.18 Million DARPA Contract and Innovative Depression Research Expand the Company's Potential

USPTO allows 26 claims for ophthalmic formulations containing quaternary chitosan derivatives, marking a key step toward U.S. patent protection.